Four-way comparative pharmacokinetics and tolerability trial of pramipexole/rasagiline: a phase I study.
Phase of Trial: Phase I
Latest Information Update: 19 Mar 2014
Price : $35 *
At a glance
- Drugs Pramipexole/rasagiline (Primary) ; Pramipexole; Rasagiline
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pharma Two B
- 19 Mar 2014 New trial record
- 18 Mar 2014 Results published in the Media Release.
- 18 Mar 2014 Full results have been reported in a Pharma Two B media release.